Michelle Melisko, MD

Duke University, B.S., Psychology / Neuroscience & Russian, 8/88-9/91
Wake Forest University School of Medicine, MD, 8/93-5/97
Resident in Internal Medicine, Stanford University Hospital, 6/97-6/00

• 2003-present
  Clinical Instructor in Medicine, UCSF Division of Hematology and Oncology
• 2005-present
  Assistant Clinical Professor, UCSF Division of Hematology and Oncology

• 1991
  Howard Hughes Undergraduate Research Grant
• 1993
  Graylyn Scholar
• 1997
  Alpha Omega Alpha Medical Honor Society
• 1997
  M. Robert Cooper Award for Excellence and Interest in Oncology
• 2003
  ASCO Merit Award Recipient
• 2004
  Breast Cancer Spore Career Development Award
• 2006
  UCSF General Clinical Research Center CreFF Award

• Melisko ME, Kunwar S, Prados M, Berger MS, Park JW. Brain metastases of breast cancer. Expert Reviews in Anticancer Therapy, Expert Rev Anticancer Ther. 2005 Apr;5(2):253-68.
• Melisko ME, Hassein F, Metzroth L, Brown B, Patel K, Moore D, Rugo HS, and Tripathy D. Patient and Physician Attitudes Toward Breast Cancer Clinical Trials: Developing Interventions Based on Understanding Barriers, Clin Breast Cancer. 2005 Apr;6(1):45-54.
• Melisko ME, Fox R, Venook A. Reactivation of Hepatitis C Virus after Chemotherapy for Colon Cancer. Clin Oncol (2004) 26: 204-205
• Edwards M, Hamolsky D, Melisko M, Hamel K, and Topp KS. Case Report: Painful peripheral neuropathy following treatment with docetaxel for breast cancer. Clinical Journal of Oncology Nursing, vol 9, no 2, April 2005: 189-193
• Park JW and Melisko ME. Resistance to Trastuzumab: Mechanistic Uncertainties. Clin Breast Cancer, vol 3, no 4, Oct 2002: 258-59